NCT00191178View on ClinicalTrials.gov

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

July 31, 2005

Conditions
Type 2 Diabetes
Interventions
DRUG

insulin lispro protamine suspension:insulin lispro rDNA origin low mix

DRUG

insulin glargine

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Charlottesville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191178 - Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter